# Anticholium® Per Se

> **NCT03013322** · NA · COMPLETED · sponsor: **University Hospital Heidelberg** · enrollment: 20 (actual)

## Conditions studied

- Shock, Septic
- Sepsis
- Perioperative Period

## Interventions

- **DRUG:** Physostigmine
- **DRUG:** Isotonic Saline

## Key facts

- **NCT ID:** NCT03013322
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-28
- **Primary completion:** 2017-02-18
- **Final completion:** 2017-02-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03013322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03013322, "Anticholium® Per Se". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03013322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*